Artelo Biosciences (ARTL) EPS (Basic) Growth (1y) (2015 - 2025)
Artelo Biosciences (ARTL) EPS (Basic) Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 322.67% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 96.41% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -16.29% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -147.33% |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - | 26.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97.28% |
| Sep 30, 2025 | 58.96% |
| Jun 30, 2025 | 24.09% |
| Mar 31, 2025 | -219.76% |
| Dec 31, 2024 | -849.09% |
| Sep 30, 2024 | -48.48% |
| Jun 30, 2024 | -23.91% |
| Mar 31, 2024 | -1.09% |
| Dec 31, 2023 | 10.66% |
| Sep 30, 2023 | -6.56% |
| Jun 30, 2023 | 28.12% |
| Mar 31, 2023 | -18.26% |
| Nov 30, 2021 | 99.94% |
| May 31, 2021 | 63.31% |
| Feb 28, 2021 | 70.33% |
| Nov 30, 2020 | 66.70% |
| May 31, 2020 | 39.98% |
| Feb 29, 2020 | -34.93% |
| Nov 30, 2019 | -77.17% |
| Aug 31, 2019 | -8.32% |